Exosomes: nanoparticles involved in cardioprotection?
Derek M Yellon1, Sean M Davidson
1From Hatter Cardiovascular Institute, Institute of Cardiovascular Science, University College London, London, United Kingdom.
Circulation Research
|January 18, 2014
Summary
Exosomes, tiny vesicles, facilitate cell communication and may protect the heart. Microvesicles, however, can promote inflammation and clotting, impacting cardiovascular health.
Area of Science:
- Cell biology
- Cardiovascular research
- Nanomedicine
Background:
- Exosomes are nanosized vesicles involved in intercellular communication, transferring molecules like proteins and nucleic acids.
- These vesicles can exhibit proangiogenic and cardioprotective effects, contrasting with larger microvesicles known for prothrombotic and proinflammatory actions.
- Exosome release is a natural cellular process, but it can be exploited in pathological conditions like cancer and infections.
Purpose of the Study:
- To review the roles of exosomes and microvesicles in normal cardiovascular physiology.
- To investigate the involvement of these vesicles in cardiovascular disease pathogenesis.
- To explore the potential of exosomes as cardiovascular biomarkers and therapeutic agents.
Main Methods:
- Literature review and evidence assessment.
- Analysis of existing studies on exosome and microvesicle function.
- Evaluation of exosome properties for cell-specific targeting and therapeutic manipulation.
Main Results:
- Exosomes play a role in normal cardiovascular function and disease.
- Microvesicles are associated with detrimental cardiovascular effects.
- Exosomes show potential as biomarkers and for non-immunogenic cardiac manipulation.
Conclusions:
- Exosomes and microvesicles have distinct and significant roles in cardiovascular health and disease.
- Exosomes represent a promising avenue for developing novel cardiovascular biomarkers and therapies.
- Further research into exosome biology could lead to new strategies for managing heart conditions.
